Effects of intermittent and chronic calorie restriction on mammalian target of rapamycin (mTOR) and IGF-I signaling pathways in mammary fat pad tissues and mammary tumors

Nutrition and Cancer

Volumn 63, Issue 3, 2011, Pages 389-401

  Dogan, Soner ^a   Johannsen, Anna C ^a   Grande, Joseph P ^b   Cleary, Margot P ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR ALPHA;

AGE; ANIMAL TISSUE; ARTICLE; BREAST; BREAST TUMOR; CALORIC RESTRICTION; CANCER PREVENTION; CHRONIC CALORIE RESTRICTION; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; INTERMETHOD COMPARISON; INTERMITTENT CALORIE RESTRICTION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ADIPOSE TISSUE; ANALYSIS OF VARIANCE; ANIMALS; BODY WEIGHT; BREAST; CALORIC RESTRICTION; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; EATING; ENERGY INTAKE; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MAMMALS; MAMMARY NEOPLASMS, EXPERIMENTAL; MAMMARY TUMOR VIRUS, MOUSE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; TRANSFORMING GROWTH FACTOR ALPHA;

MAMMALIA; MOUSE MAMMARY TUMOR VIRUS; MUS; RODENTIA;

EID: 79957568029     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2011.535968     Document Type: Article

References (51)

1. Dirx MJ, Zeegers MP, Dagnelie PC, Van Den Bogaard T, and Van Den Brandt PA: Energy restriction and the risk of spontaneous mammary tumors in mice: a meta-analysis. Int J Cancer 106, 766-770, 2003. (Pubitemid 36993402)
2. Pariza MW: Fat, calories, and mammary carcinogenesis: net energy effects. Am J Clin Nutr 45(1 Suppl), 261-263, 1987.
3. Tucker MJ: The effect of long-term food restriction on tumours in rodents. Int J Cancer 23, 803-807, 1979.
4. Gillette CA, Zhu Z, Westerlind KC, Melby CL, Wolfe P, et al.: Energy availability and mammary carcinogenesis: effects of calorie restriction and exercise. Carcinogenesis 18, 1183-1188, 1997. (Pubitemid 28132509)
5. Hursting SD, Lavigne JA, Berrigan D, Perkins SN, and Barrett JC: Calorie restriction, aging, and cancer prevention: mechanisms of action and applicability to humans. Annu Rev Med 54, 131-152, 2003. (Pubitemid 37386388)
6. Cleary MP, Hu X, Grossmann ME, Juneja SC, Dogan S, et al.: Prevention of mammary tumorigenesis by intermittent caloric restriction: does caloric intake during refeeding modulate the response? Exp Biol Med (Maywood) 232, 70-80, 2007.
7. Cleary MP, Jacobson MK, Phillips FC, Getzin SC, Grande JP, et al.: Weight-cycling decreases incidence and increases latency of mammary tumors to a greater extent than does chronic caloric restriction in mouse mammary tumor virus-transforming growth factor-alpha female mice. Cancer Epidemiol Biomarkers Prev 11, 836-843, 2002. (Pubitemid 35014886)
8. Thompson HJ, McGinley JN, Spoelstra NS, Jiang W, Zhu Z, et al.: Effect of dietary energy restriction on vascular density during mammary carcinogenesis. Cancer Res 64, 5643-5650, 2004. (Pubitemid 39095560)
9. Zhu Z, Jiang W, and Thompson HJ: An experimental paradigm for studying the cellular and molecular mechanisms of cancer inhibition by energy restriction. Mol Carcinog 35, 51-56, 2002.
10. Dogan S, Hu X, Zhang Y, Maihle NJ, Grande JP, et al.: Effects of high fat diet and/or body weight on mammary tumor leptin and apoptosis signaling pathways in MMTV-TGF-alpha mice. Breast Cancer Res 9, R91, 2007.
11. Jiang W, Zhu Z, and Thompson HJ: Effects of physical activity and restricted energy intake on chemically induced mammary carcinogenesis. Cancer Prev Res (Phila Pa) 2, 338-344, 2009.
12. Engelman RW, Day NK, Chen RF, Tomita Y, Bauer-Sardina I, et al.: Calorie consumption level influences development of C3H/Ou breast adenocarcinoma with indifference to calorie source. Proc Soc Exp Biol Med 193, 23-30, 1990. (Pubitemid 20029142)
13. Carlson JA and Hoelzel, F: Apparent prolongation of the life span of rats by intermittent fasting: one figure. J Nutr 31, 363-375, 1946.
14. Shao RP, Dao ML, Day NK, and Good RA: Dietary manipulation of mammary tumor development in adult C3H/Bi mice. Proc Soc Exp Biol Med 193, 313-317, 1990. (Pubitemid 20124767)
15. Pape-Ansorge KA, Grande JP, Christensen TA, Maihle NJ, and Cleary MP: Effect of moderate caloric restriction and/or weight cycling on mammary tumor incidence and latency in MMTV-Neu female mice. Nutr Cancer 44, 162-168, 2002.
16. Rogozina OP, Bonorden MJ, Grande JP, and Cleary MP: Serum insulin-like growth factor-i and mammary tumor development in ad libitum-fed, chronic calorie-restricted, and intermittent calorie-restricted mmtv-tgf-alpha mice. Cancer Prev Res (Phila Pa), 2, 712-719, 2009.
17. Dogan S, Rogozina OP, Lokshin AE, Grande JP, and Cleary MP: Effects of chronic vs. intermittent calorie restriction on mammary tumor incidence and serum adiponectin and leptin levels in MMTV-TGF-α mice at different ages. Oncology Letters 1, 167-176, 2010.
18. Kaaks R: Nutrition, insulin, IGF-1 metabolism, and cancer risk: a summary of epidemiological evidence. Novartis Found Symp 262, 247-260; discussion, 260-268, 2004.
19. Lukanova A, Lundin E, Zeleniuch-Jacquotte A, Muti P, Mure A, et al.: Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women. Eur J Endocrinol 150, 161-171, 2004. (Pubitemid 38312809)
20. Hankinson SE and Schernhammer ES: Insulin-like growth factor and breast cancer risk: evidence from observational studies. Breast Dis 17, 27-40, 2003. (Pubitemid 38180806)
21. Hartman J, Lindberg K, Morani A, Inzunza J, Strom A, et al.: Estrogen receptor beta inhibits angiogenesis and growth of T47D breast cancer xenografts. Cancer Res 66, 11207-11213, 2006. (Pubitemid 46009948)
22. Pyronnet S and Sonenberg N: Cell-cycle-dependent translational control. Curr Opin Genet Dev 11, 13-18, 2001. (Pubitemid 32119272)
23. Schmelzle T and Hall MN: TOR, a central controller of cell growth. Cell 103, 253-262, 2000.
24. Huang S and Houghton PJ: Inhibitors of mammalian target of rapamycin as novel antitumor agents: from bench to clinic. Curr Opin Investig Drugs 3, 295-304, 2002. (Pubitemid 34456089)
25. Mita MM, Mita A, and Rowinsky EK: The molecular target of rapamycin (mTOR) as a therapeutic target against cancer. Cancer Biol Ther, 2(Suppl 1), S169-S177, 2003.
26. Mita MM, Mita A, and Rowinsky EK: Mammalian target of rapamycin: a new molecular target for breast cancer. Clin Breast Cancer 4, 126-137, 2003. (Pubitemid 36939419)
27. Wullschleger S, Loewith R, and Hall MN: TOR signaling in growth and metabolism. Cell 124, 471-484, 2006.
28. Herberger B, Berger W, Puhalla H, Schmid K, Novak S, et al.: Simultaneous blockade of the epidermal growth factor receptor/mammalian target of rapamycin pathway by epidermal growth factor receptor inhibitors and rapamycin results in reduced cell growth and survival in biliary tract cancer cells. Mol Cancer Ther 8, 1547-1556, 2009.
29. Shaw RJ and Cantley LC: Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature 441, 424-430, 2006.
30. Zhou X, Tan M, Stone Hawthorne V, Klos KS, Lan KH, et al.: Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers. Clin Cancer Res 10, 6779-6788, 2004. (Pubitemid 39383026)
31. Cota D, Matter EK, Woods SC, and Seeley RJ: The role of hypothalamic mammalian target of rapamycin complex 1 signaling in diet-induced obesity. J Neurosci 28, 7202-7208, 2008.
32. Cota D, Proulx K, Smith KA, Kozma SC, Thomas G, et al.: Hypothalamic mTOR signaling regulates food intake. Science 312, 927-930, 2006. (Pubitemid 43727328)
33. Jiang W, Zhu Z, and Thompson HJ: Dietary energy restriction modulates the activity of AMP-activated protein kinase, Akt, and mammalian target of rapamycin in mammary carcinomas, mammary gland, and liver. Cancer Res 68, 5492-5499, 2008.
34. Khamzina L, Veilleux A, Bergeron S, and Marette A: Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance. Endocrinology 146, 1473-1481, 2005. (Pubitemid 40289337)
35. Moore T, Beltran L, Carbajal S, Strom S, Traag J, et al.: Dietary energy balance modulates signaling through the Akt/mammalian target of rapamycin pathways in multiple epithelial tissues. Cancer Prev Res (Phila Pa) 1, 65-76, 2008.
36. Engelman JA, Luo J, and Cantley LC: The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet 7, 606-619, 2006. (Pubitemid 44100518)
37. Luo J, Manning BD, and Cantley LC: Targeting the PI3K-Akt pathway in human cancer: rationale and promise. Cancer Cell 4, 257-262, 2003. (Pubitemid 37329790)
38. Matsui Y, Halter SA, Holt JT, Hogan BL, and Coffey RJ: Development of mammary hyperplasia and neoplasia in MMTV-TGF alpha transgenic mice. Cell 61, 1147-1155, 1990.
39. Lundy J, Schuss A, Stanick D, McCormack ES, Kramer S, et al.: Expression of neu protein, epidermal growth factor receptor, and transforming growth factor alpha in breast cancer. Correlation with clinicopathologic parameters. Am J Pathol 138, 1527-1534, 1991.
40. Murray PA, Barrett-Lee P, Travers M, Luqmani Y, Powles T, et al.: The prognostic significance of transforming growth factors in human breast cancer. Br J Cancer 67, 1408-1412, 1993. (Pubitemid 23172888)
41. Rajkumar T and Gullick WJ: The type I growth factor receptors in human breast cancer. Breast Cancer Res Treat 29, 3-9, 1994. (Pubitemid 24104833)
42. Panico L, D'Antonio A, Salvatore G, Mezza E, Tortora G, et al.: Differential immunohistochemical detection of transforming growth factor alpha, amphiregulin and CRIPTO in human normal and malignant breast tissues. Int J Cancer 65, 51-56, 1996. (Pubitemid 26030937)
43. Reeves PG, Nielsen FH, and Fahey GC, Jr.: AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123, 1939-1951, 1993.
44. Cleary MP, Grande JP, and Maihle NJ: Effect of high-fat diet on body weight and mammary tumor latency in MMTV-TGF-alpha mice. Int J Obes Relat Metab Disord 28, 956-962, 2004. (Pubitemid 38998699)
45. Hardie DG and Carling D: The AMP-activated protein kinase - fuel gauge of the mammalian cell? Eur J Biochem 246, 259-273, 1997.
46. Lindsley JE and Rutter J: Nutrient sensing and metabolic decisions. Comp Biochem Physiol B Biochem Mol Biol 139, 543-559, 2004. (Pubitemid 39586542)
47. Martin TL, Alquier T, Asakura K, Furukawa N, Preitner F, et al.: Diet-induced obesity alters AMP kinase activity in hypothalamus and skeletal muscle. J Biol Chem 281, 18933-18941, 2006. (Pubitemid 44035396)
48. Kahn BB, Alquier T, Carling D, and Hardie DG: AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 1, 15-25, 2005. (Pubitemid 43960587)
49. Woods A, Johnstone SR, Dickerson K, Leiper FC, Fryer LG, et al.: LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr Biol 13, 2004-2008, 2003.
50. Minokoshi Y, Alquier T, Furukawa N, Kim YB, Lee A, et al.: AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 428, 569-574, 2004. (Pubitemid 38480541)
51. Gonzalez AA, Kumar R, Mulligan JD, Davis AJ, Weindruch R, et al.: Metabolic adaptations to fasting and chronic caloric restriction in heart, muscle, and liver do not include changes in AMPK activity. Am J Physiol Endocrinol Metab 287, E1032-1037, 2004.